A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition Meeting Abstract
| Authors: | Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Jongen-Lavrencic, M.; Altman, J. K.; Dohner, H.; Thomson, B.; Blakemore, S. J.; Daigle, S.; Fine, G.; Waters, N. J.; Krivtsov, A. V.; Koche, R.; Armstrong, S. A.; Ho, P. T.; Lowenberg, B.; Tallman, M. S. |
| Abstract Title: | A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368020102059 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.2547.2547 |
| Notes: | Meeting Abstract: 2547 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work